Company

Samsung Bioepis

Samsung Bioepis — Biopharmaceutical company partnered with Teva on biosimilars. Every TV10 Global story that covers or mentions Samsung Bioepis, translated into English from TV10's Hebrew reporting.

Type
Company

1 story on TV10 Global

Teva stock
Above expectations

Teva Reports Revenue of $4.4 Billion

Adjusted gross profit margin soared to a decade high of 58.7% • The company raised its annual revenue forecast following sharp growth in innovative medicines

Shai Nogai